These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
327 related items for PubMed ID: 19564547
21. Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats. Ikeda Y, Nakamura T, Takano H, Kimura H, Obata JE, Takeda S, Hata A, Shido K, Mochizuki S, Yoshida Y. J Lab Clin Med; 2000 Apr; 135(4):353-9. PubMed ID: 10779052 [Abstract] [Full Text] [Related]
22. Temocapril prevents transition to diastolic heart failure in rats even if initiated after appearance of LV hypertrophy and diastolic dysfunction. Sakata Y, Yamamoto K, Mano T, Nishikawa N, Yoshida J, Miwa T, Hori M, Masuyama T. Cardiovasc Res; 2003 Mar; 57(3):757-65. PubMed ID: 12618237 [Abstract] [Full Text] [Related]
23. Rosuvastatin reduces platelet activation in heart failure: role of NO bioavailability. Schäfer A, Fraccarollo D, Eigenthaler M, Tas P, Firnschild A, Frantz S, Ertl G, Bauersachs J. Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1071-7. PubMed ID: 15761193 [Abstract] [Full Text] [Related]
24. Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats. Iwanaga Y, Kihara Y, Hasegawa K, Inagaki K, Yoneda T, Kaburagi S, Araki M, Sasayama S. Circulation; 1998 Nov 10; 98(19):2065-73. PubMed ID: 9808606 [Abstract] [Full Text] [Related]
25. Combined atorvastatin and coenzyme Q10 improve the left ventricular function in isoproterenol-induced heart failure in rat. Garjani A, Andalib S, Biabani S, Soraya H, Doustar Y, Garjani A, Maleki-Dizaji N. Eur J Pharmacol; 2011 Sep 10; 666(1-3):135-41. PubMed ID: 21570962 [Abstract] [Full Text] [Related]
26. Rosuvastatin changes cytokine expressions in ischemic territory and preserves heart function after acute myocardial infarction in rats. Hu X, Sun A, Xie X, Huang Z, Jia J, Yao R, Ge J. J Cardiovasc Pharmacol Ther; 2013 Mar 10; 18(2):162-76. PubMed ID: 23139358 [Abstract] [Full Text] [Related]
28. Rosuvastatin-attenuated heart failure in aged spontaneously hypertensive rats via PKCα/β2 signal pathway. Qiu Z, Zhang W, Fan F, Li H, Wu C, Ye Y, Du Q, Li Z, Hu X, Zhao G, Sun A, Bao Z, Ge J. J Cell Mol Med; 2012 Dec 10; 16(12):3052-61. PubMed ID: 22970977 [Abstract] [Full Text] [Related]
30. Rosuvastatin provides pleiotropic protection against pulmonary hypertension, right ventricular hypertrophy, and coronary endothelial dysfunction in rats. Sun X, Ku DD. Am J Physiol Heart Circ Physiol; 2008 Feb 10; 294(2):H801-9. PubMed ID: 18055512 [Abstract] [Full Text] [Related]
31. Waon therapy attenuates cardiac hypertrophy and promotes myocardial capillary growth in hypertensive rats: a comparative study with fluvastatin. Ihori H, Nozawa T, Sobajima M, Shida T, Fukui Y, Fujii N, Inoue H. Heart Vessels; 2016 Aug 10; 31(8):1361-9. PubMed ID: 26686369 [Abstract] [Full Text] [Related]
32. Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial. Ghio S, Scelsi L, Latini R, Masson S, Eleuteri E, Palvarini M, Vriz O, Pasotti M, Gorini M, Marchioli R, Maggioni A, Tavazzi L, GISSI-HF investigators. Eur J Heart Fail; 2010 Dec 10; 12(12):1345-53. PubMed ID: 20952767 [Abstract] [Full Text] [Related]
33. HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome. Hermida N, Markl A, Hamelet J, Van Assche T, Vanderper A, Herijgers P, van Bilsen M, Hilfiker-Kleiner D, Noppe G, Beauloye C, Horman S, Balligand JL. Cardiovasc Res; 2013 Jul 01; 99(1):44-54. PubMed ID: 23542580 [Abstract] [Full Text] [Related]
34. Chronic monotherapy with rosuvastatin prevents progressive left ventricular dysfunction and remodeling in dogs with heart failure. Zacà V, Rastogi S, Imai M, Wang M, Sharov VG, Jiang A, Goldstein S, Sabbah HN. J Am Coll Cardiol; 2007 Aug 07; 50(6):551-7. PubMed ID: 17678740 [Abstract] [Full Text] [Related]
35. Rosuvastatin prevents pressure overload‑induced myocardial hypertrophy via inactivation of the Akt, ERK1/2 and GATA4 signaling pathways in rats. Xu X, Zhang L, Liang J. Mol Med Rep; 2013 Aug 07; 8(2):385-92. PubMed ID: 23799547 [Abstract] [Full Text] [Related]
37. Beneficial effect of rosuvastatin on cardiac dysfunction is associated with alterations in calcium-regulatory proteins. Yang Y, Mou Y, Hu SJ, Fu M. Eur J Heart Fail; 2009 Jan 07; 11(1):6-13. PubMed ID: 19147451 [Abstract] [Full Text] [Related]
38. Rosuvastatin inhibits TGF-beta1 expression and alleviates myocardial fibrosis in diabetic rats. Ma YX, Li WH, Xie Q. Pharmazie; 2013 May 07; 68(5):355-8. PubMed ID: 23802433 [Abstract] [Full Text] [Related]
39. Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure. Krum H, Ashton E, Reid C, Kalff V, Rogers J, Amarena J, Singh B, Tonkin A. J Card Fail; 2007 Feb 07; 13(1):1-7. PubMed ID: 17338996 [Abstract] [Full Text] [Related]
40. Effects of HMG-CoA reductase inhibitor on experimental autoimmune myocarditis. Liu X, Li B, Wang W, Zhang C, Zhang M, Zhang Y, Xia Y, Dong Z, Guo Y, An F. Cardiovasc Drugs Ther; 2012 Apr 07; 26(2):121-30. PubMed ID: 22382902 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]